Clinical Trials Browser

Phase 2 × Colitis, Ulcerative × 1 year × Clear all

Colitis, Ulcerative, Lymphoma, Follicular

NCT07223424 2026-04-16

PSI-Immune

DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma Of Esophagus, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Colitis, Ulcerative, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma

NCT04767984 2026-01-21

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

Phase 2 Active not recruiting

42 enrolled

Gastrointestinal

Colitis, Ulcerative, Colorectal Neoplasms

NCT03760003 2025-11-28

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Phase 2 Completed

355 enrolled 39 charts

Colitis, Ulcerative

NCT05785715 2025-07-01

Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis

Phase 2 Terminated

81 enrolled

Lymphoid

Colitis, Ulcerative, Lymphoma, Follicular

Clinical Trials

VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

PSI-Immune

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis